Global Antibacterial Therapeutic Market Research Report 2023

Report ID: 1982973 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antibacterial Therapeutic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Penicillins
        1.2.3 Cephalosporins
        1.2.4 Quinolone
        1.2.5 Aminoglycosides
        1.2.6 Monobactams
        1.2.7 Carbapenems
        1.2.8 Macrolides
        1.2.9 Others
    1.3 Market by Application
        1.3.1 Global Antibacterial Therapeutic Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Oral
        1.3.3 Topical
        1.3.4 Parenteral
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Antibacterial Therapeutic Market Perspective (2017-2028)
    2.2 Antibacterial Therapeutic Growth Trends by Region
        2.2.1 Antibacterial Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Antibacterial Therapeutic Historic Market Size by Region (2017-2022)
        2.2.3 Antibacterial Therapeutic Forecasted Market Size by Region (2023-2028)
    2.3 Antibacterial Therapeutic Market Dynamics
        2.3.1 Antibacterial Therapeutic Industry Trends
        2.3.2 Antibacterial Therapeutic Market Drivers
        2.3.3 Antibacterial Therapeutic Market Challenges
        2.3.4 Antibacterial Therapeutic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Antibacterial Therapeutic Players by Revenue
        3.1.1 Global Top Antibacterial Therapeutic Players by Revenue (2017-2022)
        3.1.2 Global Antibacterial Therapeutic Revenue Market Share by Players (2017-2022)
    3.2 Global Antibacterial Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Antibacterial Therapeutic Revenue
    3.4 Global Antibacterial Therapeutic Market Concentration Ratio
        3.4.1 Global Antibacterial Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antibacterial Therapeutic Revenue in 2021
    3.5 Antibacterial Therapeutic Key Players Head office and Area Served
    3.6 Key Players Antibacterial Therapeutic Product Solution and Service
    3.7 Date of Enter into Antibacterial Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Antibacterial Therapeutic Breakdown Data by Type
    4.1 Global Antibacterial Therapeutic Historic Market Size by Type (2017-2022)
    4.2 Global Antibacterial Therapeutic Forecasted Market Size by Type (2023-2028)
5 Antibacterial Therapeutic Breakdown Data by Application
    5.1 Global Antibacterial Therapeutic Historic Market Size by Application (2017-2022)
    5.2 Global Antibacterial Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Antibacterial Therapeutic Market Size (2017-2028)
    6.2 North America Antibacterial Therapeutic Market Size by Country (2017-2022)
    6.3 North America Antibacterial Therapeutic Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Antibacterial Therapeutic Market Size (2017-2028)
    7.2 Europe Antibacterial Therapeutic Market Size by Country (2017-2022)
    7.3 Europe Antibacterial Therapeutic Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Antibacterial Therapeutic Market Size (2017-2028)
    8.2 Asia-Pacific Antibacterial Therapeutic Market Size by Country (2017-2022)
    8.3 Asia-Pacific Antibacterial Therapeutic Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Antibacterial Therapeutic Market Size (2017-2028)
    9.2 Latin America Antibacterial Therapeutic Market Size by Country (2017-2022)
    9.3 Latin America Antibacterial Therapeutic Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Antibacterial Therapeutic Market Size (2017-2028)
    10.2 Middle East & Africa Antibacterial Therapeutic Market Size by Country (2017-2022)
    10.3 Middle East & Africa Antibacterial Therapeutic Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Antibacterial Therapeutic Introduction
        11.1.4 Abbott Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 Daiichi Sankyo
        11.2.1 Daiichi Sankyo Company Detail
        11.2.2 Daiichi Sankyo Business Overview
        11.2.3 Daiichi Sankyo Antibacterial Therapeutic Introduction
        11.2.4 Daiichi Sankyo Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.2.5 Daiichi Sankyo Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Antibacterial Therapeutic Introduction
        11.3.4 Pfizer Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Takeda
        11.4.1 Takeda Company Detail
        11.4.2 Takeda Business Overview
        11.4.3 Takeda Antibacterial Therapeutic Introduction
        11.4.4 Takeda Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.4.5 Takeda Recent Development
    11.5 Eli Lilly
        11.5.1 Eli Lilly Company Detail
        11.5.2 Eli Lilly Business Overview
        11.5.3 Eli Lilly Antibacterial Therapeutic Introduction
        11.5.4 Eli Lilly Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.5.5 Eli Lilly Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Detail
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Antibacterial Therapeutic Introduction
        11.6.4 Novartis Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.6.5 Novartis Recent Development
    11.7 Sanofi
        11.7.1 Sanofi Company Detail
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Antibacterial Therapeutic Introduction
        11.7.4 Sanofi Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.7.5 Sanofi Recent Development
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Detail
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Antibacterial Therapeutic Introduction
        11.8.4 AstraZeneca Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.8.5 AstraZeneca Recent Development
    11.9 Bayer
        11.9.1 Bayer Company Detail
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Antibacterial Therapeutic Introduction
        11.9.4 Bayer Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.9.5 Bayer Recent Development
    11.10 Merck
        11.10.1 Merck Company Detail
        11.10.2 Merck Business Overview
        11.10.3 Merck Antibacterial Therapeutic Introduction
        11.10.4 Merck Revenue in Antibacterial Therapeutic Business (2017-2022)
        11.10.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Antibacterial Therapeutic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Penicillins
    Table 3. Key Players of Cephalosporins
    Table 4. Key Players of Quinolone
    Table 5. Key Players of Aminoglycosides
    Table 6. Key Players of Monobactams
    Table 7. Key Players of Carbapenems
    Table 8. Key Players of Macrolides
    Table 9. Key Players of Others
    Table 10. Global Antibacterial Therapeutic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Antibacterial Therapeutic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Antibacterial Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Antibacterial Therapeutic Market Share by Region (2017-2022)
    Table 14. Global Antibacterial Therapeutic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Antibacterial Therapeutic Market Share by Region (2023-2028)
    Table 16. Antibacterial Therapeutic Market Trends
    Table 17. Antibacterial Therapeutic Market Drivers
    Table 18. Antibacterial Therapeutic Market Challenges
    Table 19. Antibacterial Therapeutic Market Restraints
    Table 20. Global Antibacterial Therapeutic Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Antibacterial Therapeutic Market Share by Players (2017-2022)
    Table 22. Global Top Antibacterial Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibacterial Therapeutic as of 2021)
    Table 23. Ranking of Global Top Antibacterial Therapeutic Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Antibacterial Therapeutic Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Antibacterial Therapeutic Product Solution and Service
    Table 27. Date of Enter into Antibacterial Therapeutic Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Antibacterial Therapeutic Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Antibacterial Therapeutic Revenue Market Share by Type (2017-2022)
    Table 31. Global Antibacterial Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Antibacterial Therapeutic Revenue Market Share by Type (2023-2028)
    Table 33. Global Antibacterial Therapeutic Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Antibacterial Therapeutic Revenue Market Share by Application (2017-2022)
    Table 35. Global Antibacterial Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Antibacterial Therapeutic Revenue Market Share by Application (2023-2028)
    Table 37. North America Antibacterial Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Antibacterial Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Antibacterial Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Europe Antibacterial Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Asia-Pacific Antibacterial Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 42. Asia-Pacific Antibacterial Therapeutic Market Size by Region (2023-2028) & (US$ Million)
    Table 43. Latin America Antibacterial Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Latin America Antibacterial Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Middle East & Africa Antibacterial Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Middle East & Africa Antibacterial Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Abbott Company Detail
    Table 48. Abbott Business Overview
    Table 49. Abbott Antibacterial Therapeutic Product
    Table 50. Abbott Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 51. Abbott Recent Development
    Table 52. Daiichi Sankyo Company Detail
    Table 53. Daiichi Sankyo Business Overview
    Table 54. Daiichi Sankyo Antibacterial Therapeutic Product
    Table 55. Daiichi Sankyo Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 56. Daiichi Sankyo Recent Development
    Table 57. Pfizer Company Detail
    Table 58. Pfizer Business Overview
    Table 59. Pfizer Antibacterial Therapeutic Product
    Table 60. Pfizer Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 61. Pfizer Recent Development
    Table 62. Takeda Company Detail
    Table 63. Takeda Business Overview
    Table 64. Takeda Antibacterial Therapeutic Product
    Table 65. Takeda Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 66. Takeda Recent Development
    Table 67. Eli Lilly Company Detail
    Table 68. Eli Lilly Business Overview
    Table 69. Eli Lilly Antibacterial Therapeutic Product
    Table 70. Eli Lilly Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 71. Eli Lilly Recent Development
    Table 72. Novartis Company Detail
    Table 73. Novartis Business Overview
    Table 74. Novartis Antibacterial Therapeutic Product
    Table 75. Novartis Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 76. Novartis Recent Development
    Table 77. Sanofi Company Detail
    Table 78. Sanofi Business Overview
    Table 79. Sanofi Antibacterial Therapeutic Product
    Table 80. Sanofi Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 81. Sanofi Recent Development
    Table 82. AstraZeneca Company Detail
    Table 83. AstraZeneca Business Overview
    Table 84. AstraZeneca Antibacterial Therapeutic Product
    Table 85. AstraZeneca Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 86. AstraZeneca Recent Development
    Table 87. Bayer Company Detail
    Table 88. Bayer Business Overview
    Table 89. Bayer Antibacterial Therapeutic Product
    Table 90. Bayer Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 91. Bayer Recent Development
    Table 92. Merck Company Detail
    Table 93. Merck Business Overview
    Table 94. Merck Antibacterial Therapeutic Product
    Table 95. Merck Revenue in Antibacterial Therapeutic Business (2017-2022) & (US$ Million)
    Table 96. Merck Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antibacterial Therapeutic Market Share by Type: 2021 VS 2028
    Figure 2. Penicillins Features
    Figure 3. Cephalosporins Features
    Figure 4. Quinolone Features
    Figure 5. Aminoglycosides Features
    Figure 6. Monobactams Features
    Figure 7. Carbapenems Features
    Figure 8. Macrolides Features
    Figure 9. Others Features
    Figure 10. Global Antibacterial Therapeutic Market Share by Application in 2021 & 2028
    Figure 11. Oral Case Studies
    Figure 12. Topical Case Studies
    Figure 13. Parenteral Case Studies
    Figure 14. Others Case Studies
    Figure 15. Antibacterial Therapeutic Report Years Considered
    Figure 16. Global Antibacterial Therapeutic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 17. Global Antibacterial Therapeutic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Antibacterial Therapeutic Market Share by Region: 2021 VS 2028
    Figure 19. Global Antibacterial Therapeutic Market Share by Players in 2021
    Figure 20. Global Top Antibacterial Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibacterial Therapeutic as of 2021)
    Figure 21. The Top 10 and 5 Players Market Share by Antibacterial Therapeutic Revenue in 2021
    Figure 22. North America Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. North America Antibacterial Therapeutic Market Share by Country (2017-2028)
    Figure 24. United States Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Antibacterial Therapeutic Market Share by Country (2017-2028)
    Figure 28. Germany Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Antibacterial Therapeutic Market Share by Region (2017-2028)
    Figure 36. China Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Antibacterial Therapeutic Market Share by Country (2017-2028)
    Figure 44. Mexico Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Antibacterial Therapeutic Market Share by Country (2017-2028)
    Figure 48. Turkey Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Saudi Arabia Antibacterial Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Abbott Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 51. Daiichi Sankyo Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 52. Pfizer Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 53. Takeda Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 54. Eli Lilly Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 55. Novartis Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 56. Sanofi Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 57. AstraZeneca Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 58. Bayer Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Antibacterial Therapeutic Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Daiichi Sankyo
Pfizer
Takeda
Eli Lilly
Novartis
Sanofi
AstraZeneca
Bayer
Merck
Frequently Asked Questions
Antibacterial Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antibacterial Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antibacterial Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Antiemetics

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Antifungal Agents

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More